Mahathir Bayena

Elsight (ASX:ELS) has commenced delivery of its first Aura platform units to a leading defence contractor, following the completion of development and testing for the program announced on Sept. 25, 2024.

AdAlta (ASX:1AD) and its cellular immunotherapy subsidiary, AdCella, have announced a major global collaboration with Shanghai Cell Therapy Group to co-develop the first-in-class CAR-T therapy, BZDS1901, for markets outside Greater China.

Sphere Corp. has entered into a strategic partnership to acquire a 10% interest in the ENC HPAL Project.

Autonomous artificial intelligence agents capable of creating and promoting their own cryptocurrencies could pose a serious challenge to human control over monetary systems, according to Zoltan Istvan, a leading voice in transhumanist thought.

Russia is seeking to impose prison sentences and forced labour on illegal Bitcoin miners accused of straining national power grids.

Bulgaria enters the eurozone amid political instability and a nation divided over replacing the lev with the euro.

Chainlink cemented its role as the backbone of onchain finance in 2025, with governments and global banks adopting its standards for real world blockchain use.

Protests in Iran have intensified for a fourth day as demonstrators targeted a government building, driven by anger over a collapsing currency and economic pressure.

DigitalBridge (NYSE:DBRG) and Crestview Partners have completed their $1.5 billion take-private acquisition of WideOpenWest (WOW!), concluding the transaction on December 31, 2025.

FibroBiologics (NASDAQ:FBLG) took a decisive step toward clinical-stage operations on Wednesday, filing an Investigational New Drug (IND) application with the U.S. Food and Drug Administration to begin Phase 1/2 trials for its lead psoriasis candidate, CYPS317.